Editas Medicine, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2.8M | 24.7M | 7.5M | 3.6M | 4.7M | 30.6M | 61K | 513K |
| Cost of Goods Sold | 483K | 0 | 19.8M | 16.2M | 26.6M | 48.6M | 1.6M | 1.4M |
| Gross Profit | 2.3M | 24.7M | -12.2M | -12.6M | -21.9M | -18.0M | -1.5M | -907K |
| R&D Expenses | 2.8M | 27.4M | 19.8M | 16.2M | 26.6M | 48.6M | 47.6M | 52.8M |
| Operating Expenses | 27.4M | 38.8M | 12.3M | 38.9M | 54.2M | 28.6M | 64.1M | 71.0M |
| Operating Income | -25.0M | -14.0M | -24.5M | -51.5M | -76.2M | -46.6M | -65.7M | -71.9M |
| Other Income / Gains | 21K | 8.4M | -569K | -1.7M | 75K | 1.2M | 3.5M | 4.3M |
| Net Income | -25.0M | -5.6M | -25.1M | -53.2M | -76.1M | -45.4M | -62.1M | -67.6M |
| EPS (Diluted) | -0.26 | -0.058 | -0.28 | -0.63 | -0.92 | -0.55 | -0.75 | -0.82 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.829 | 1.00 | -1.622 | -3.522 | -4.709 | -0.588 | -25.213 | -1.768 |
| General And Administrative Expenses | 10.2M | 11.4M | 12.3M | 12.9M | 13.4M | 16.4M | 18.1M | 18.2M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 10.2M | 11.4M | 12.3M | 12.9M | 13.4M | 16.4M | 18.1M | 18.2M |
| Other Expenses | 14.3M | 0 | -19.8M | 9.9M | 14.3M | -36.4M | -1.6M | 0 |
| Cost And Expenses | 27.8M | 38.8M | 32.1M | 55.1M | 80.8M | 77.2M | 65.7M | 72.4M |
| Interest Income | 1.2M | -6.6M | 1.8M | 2.1M | 2.7M | 1.2M | 3.5M | 4.3M |
| Interest Expense | 1.1M | -6.6M | 2.4M | 2.0M | 2.2M | 0 | 0 | 0 |
| Depreciation And Amortization | 483K | 805K | 721K | 1.8M | 1.9M | 1.4M | 1.6M | 1.4M |
| Ebitda | -23.4M | -5.3M | -22.0M | -49.4M | -72.0M | -33.0M | -60.5M | -66.2M |
| Ebitdaratio | -8.275 | -0.213 | -2.916 | -13.801 | -15.448 | -1.078 | -992.492 | -129.019 |
| Operating Income Ratio | -8.832 | -0.567 | -3.254 | -14.406 | -16.351 | -1.522 | -1K | -140.162 |
| Income Before Tax | -25.0M | -5.6M | -25.1M | -53.2M | -76.1M | -45.4M | -62.1M | -67.6M |
| Income Before Tax Ratio | -8.824 | -0.227 | -3.33 | -14.878 | -16.335 | -1.483 | -1K | -131.788 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -8.824 | -0.227 | -3.33 | -14.878 | -16.335 | -1.483 | -1K | -131.788 |
| Epsdiluted | -0.26 | -0.058 | -0.28 | -0.63 | -0.92 | -0.55 | -0.75 | -0.82 |
| Weighted Average Shs Out | 97.9M | 88.7M | 90.1M | 84.4M | 83.1M | 82.6M | 82.5M | 82.3M |
| Weighted Average Shs Out Dil | 97.9M | 88.7M | 90.1M | 84.4M | 83.1M | 82.6M | 82.5M | 82.3M |